España
Italia
대한민ęµ
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민ęµ
日本
Français
Login
Register
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Cancer Therapies
Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains
Amgen Shares Dip On Light 2021 Outlook, Paused Studies
HC Wainwright: G1 Therapeutics Is Targeting 'Potential Blockbuster' Oncology Markets
Amgen Shares Dip On Light 2021 Outlook, Paused Studies
HC Wainwright: G1 Therapeutics Is Targeting 'Potential Blockbuster' Oncology Markets
Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
Checkpoint Therapeutics Wins A New Bull As Company's 'Plan Is Quickly Coming Together'
Gilead's Yescarta Cancer Treatment Approved, Some Analysts Shrug
Read More...
Cancer Therapies Recent News
Puma Biotech Makes Big Breakthrough In Breast Cancer Treatment
Today's Top Mover: HTG Molecular Soars 60%
Everything We Know About Merck's Keytruda
Transgemonic Up Another 33% Following Yesterday's 295% Run
FDA Approves Clovis Oncology's Ovarian Cancer Treatment
ZIOPHARM Announces Clinical Data On Brain Cancer Drug
Citi Sees 26% Upside In TESARO On The Strength Of Trial Data
Compugen Achieves Milestone Event With Bayer
Spectrum Pharmaceuticals Gains 5% After Company Confirms FDA Review Of New Drug
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Here's Why Shares Of TrovaGene Are Surging
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started